Cargando…

Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations

PURPOSE: Measuring longitudinal changes in amyloid load in the asymptomatic stage of Alzheimer’s disease is of high relevance for clinical research and progress towards more efficacious, timely treatments. Apolipoprotein E ε4 (APOE4) has a well-established effect on the rate of amyloid accumulation....

Descripción completa

Detalles Bibliográficos
Autores principales: Luckett, Emma S., Schaeverbeke, Jolien, De Meyer, Steffi, Adamczuk, Katarzyna, Van Laere, Koen, Dupont, Patrick, Vandenberghe, Rik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850036/
https://www.ncbi.nlm.nih.gov/pubmed/36621019
http://dx.doi.org/10.1016/j.nicl.2023.103321
_version_ 1784872091424653312
author Luckett, Emma S.
Schaeverbeke, Jolien
De Meyer, Steffi
Adamczuk, Katarzyna
Van Laere, Koen
Dupont, Patrick
Vandenberghe, Rik
author_facet Luckett, Emma S.
Schaeverbeke, Jolien
De Meyer, Steffi
Adamczuk, Katarzyna
Van Laere, Koen
Dupont, Patrick
Vandenberghe, Rik
author_sort Luckett, Emma S.
collection PubMed
description PURPOSE: Measuring longitudinal changes in amyloid load in the asymptomatic stage of Alzheimer’s disease is of high relevance for clinical research and progress towards more efficacious, timely treatments. Apolipoprotein E ε4 (APOE4) has a well-established effect on the rate of amyloid accumulation. Here we investigated which region of interest and which reference region perform best at detecting the effect of APOE4 on longitudinal amyloid load in individuals participating in the Flemish Prevent Alzheimer’s Disease Cohort KU Leuven (F-PACK). METHODS: Ninety cognitively intact F-PACK participants (baseline age: 68 (52–80) years, 46 males, 42 APOE4 carriers) received structural MRI and (18)F-Flutemetamol PET scans at baseline and follow-up (6.2 (3.4–10.9) year interval). Standardised uptake value ratios (SUVRs) and Centiloids (CLs) were calculated in a composite cortical volume of interest (SUVR(comp)/CL) and in the precuneus (SUVR(prec)), and amyloid rate of change derived: (follow-up amyloid load – baseline amyloid load) / time interval (years). Four reference regions were used to derive amyloid load: whole cerebellum, cerebellar grey matter, eroded subcortical white matter, and pons. RESULTS: When using whole cerebellum or cerebellar grey matter as reference region, APOE4 carriers had a significantly higher SUVR(comp) amyloid rate of change than non-carriers (p(corr) = 0.004, t = 3.40 (CI 0.005–0.018); p(corr) = 0.036, t = 2.66 (CI 0.003–0.018), respectively). Significance was not observed for eroded subcortical white matter or pons (p(corr) = 0.144, t = 2.13 (CI 0.0003–0.008); p(corr) = 0.116, t = 2.22 (CI 0.005–0.010), respectively). When using CLs as the amyloid measurement, and whole cerebellum, APOE4 carriers had a higher amyloid rate of change than non-carriers (p(corr) = 0.012, t = 3.05 (CI 0.499–2.359)). Significance was not observed for the other reference regions. No significance was observed with any of the reference regions and amyloid rate of change in the precuneus (SUVR(prec)). CONCLUSION: In this cognitively intact cohort, a composite neocortical volume of interest together with whole cerebellum or cerebellar grey matter as reference region are the methods of choice for detecting APOE4-dependent differences in amyloid rate of change.
format Online
Article
Text
id pubmed-9850036
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98500362023-01-20 Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations Luckett, Emma S. Schaeverbeke, Jolien De Meyer, Steffi Adamczuk, Katarzyna Van Laere, Koen Dupont, Patrick Vandenberghe, Rik Neuroimage Clin Regular Article PURPOSE: Measuring longitudinal changes in amyloid load in the asymptomatic stage of Alzheimer’s disease is of high relevance for clinical research and progress towards more efficacious, timely treatments. Apolipoprotein E ε4 (APOE4) has a well-established effect on the rate of amyloid accumulation. Here we investigated which region of interest and which reference region perform best at detecting the effect of APOE4 on longitudinal amyloid load in individuals participating in the Flemish Prevent Alzheimer’s Disease Cohort KU Leuven (F-PACK). METHODS: Ninety cognitively intact F-PACK participants (baseline age: 68 (52–80) years, 46 males, 42 APOE4 carriers) received structural MRI and (18)F-Flutemetamol PET scans at baseline and follow-up (6.2 (3.4–10.9) year interval). Standardised uptake value ratios (SUVRs) and Centiloids (CLs) were calculated in a composite cortical volume of interest (SUVR(comp)/CL) and in the precuneus (SUVR(prec)), and amyloid rate of change derived: (follow-up amyloid load – baseline amyloid load) / time interval (years). Four reference regions were used to derive amyloid load: whole cerebellum, cerebellar grey matter, eroded subcortical white matter, and pons. RESULTS: When using whole cerebellum or cerebellar grey matter as reference region, APOE4 carriers had a significantly higher SUVR(comp) amyloid rate of change than non-carriers (p(corr) = 0.004, t = 3.40 (CI 0.005–0.018); p(corr) = 0.036, t = 2.66 (CI 0.003–0.018), respectively). Significance was not observed for eroded subcortical white matter or pons (p(corr) = 0.144, t = 2.13 (CI 0.0003–0.008); p(corr) = 0.116, t = 2.22 (CI 0.005–0.010), respectively). When using CLs as the amyloid measurement, and whole cerebellum, APOE4 carriers had a higher amyloid rate of change than non-carriers (p(corr) = 0.012, t = 3.05 (CI 0.499–2.359)). Significance was not observed for the other reference regions. No significance was observed with any of the reference regions and amyloid rate of change in the precuneus (SUVR(prec)). CONCLUSION: In this cognitively intact cohort, a composite neocortical volume of interest together with whole cerebellum or cerebellar grey matter as reference region are the methods of choice for detecting APOE4-dependent differences in amyloid rate of change. Elsevier 2023-01-05 /pmc/articles/PMC9850036/ /pubmed/36621019 http://dx.doi.org/10.1016/j.nicl.2023.103321 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Luckett, Emma S.
Schaeverbeke, Jolien
De Meyer, Steffi
Adamczuk, Katarzyna
Van Laere, Koen
Dupont, Patrick
Vandenberghe, Rik
Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
title Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
title_full Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
title_fullStr Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
title_full_unstemmed Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
title_short Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
title_sort longitudinal changes in (18)f-flutemetamol amyloid load in cognitively intact apoe4 carriers versus noncarriers: methodological considerations
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850036/
https://www.ncbi.nlm.nih.gov/pubmed/36621019
http://dx.doi.org/10.1016/j.nicl.2023.103321
work_keys_str_mv AT luckettemmas longitudinalchangesin18fflutemetamolamyloidloadincognitivelyintactapoe4carriersversusnoncarriersmethodologicalconsiderations
AT schaeverbekejolien longitudinalchangesin18fflutemetamolamyloidloadincognitivelyintactapoe4carriersversusnoncarriersmethodologicalconsiderations
AT demeyersteffi longitudinalchangesin18fflutemetamolamyloidloadincognitivelyintactapoe4carriersversusnoncarriersmethodologicalconsiderations
AT adamczukkatarzyna longitudinalchangesin18fflutemetamolamyloidloadincognitivelyintactapoe4carriersversusnoncarriersmethodologicalconsiderations
AT vanlaerekoen longitudinalchangesin18fflutemetamolamyloidloadincognitivelyintactapoe4carriersversusnoncarriersmethodologicalconsiderations
AT dupontpatrick longitudinalchangesin18fflutemetamolamyloidloadincognitivelyintactapoe4carriersversusnoncarriersmethodologicalconsiderations
AT vandenbergherik longitudinalchangesin18fflutemetamolamyloidloadincognitivelyintactapoe4carriersversusnoncarriersmethodologicalconsiderations